REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

12 Apr 2022 07:00

RNS Number : 0315I
Electrocomponents PLC
12 April 2022
 

12 April 2022, 7.00am

 

Electrocomponents plc today issues a trading update for the year ended 31 March 2022, ahead of publishing full-year results on 24 May 2022

 

Like-for-like revenue growth1

Region

Q1 toJun 2021

Q2 toSep 2021

Q3 toDec 2021

Q4 toMar 2022

Year to Mar 2022

EMEA

37%

22%

14%

19%

22%

Americas

40%

35%

37%

33%

36%

Asia Pacific

31%

31%

25%

23%

27%

Group

37%

26%

21%

23%

26%

 

 

Group like-for-like revenue growth for the year ended 31 March 2022 was 26%. Please refer to our commentary accompanying the recent trading update released on 9 March 2022 for more detail. As reported on 30 March 2022, we expect our full year adjusted operating profit margin to be at the top end of the consensus range2. Due to our trading update on 9 March 2022 and Investor Event on 30 March 2022, there will be no conference call taking place today. Webcasts from both are on our website www.electrocomponents.com/investors/financial-results.

 

As previously announced, in early May Electrocomponents plc will become RS Group plc as we strengthen our position as one brand, united behind our single purpose of 'making amazing happen for a better world'. An announcement will be made when the name change becomes effective with a revised stock TIDM (ticker). Until such an announcement is made, trading will continue under the existing ticker 'ECM'. No action is required on the part of any shareholder.

 

 

Enquiries:

David Egan

Chief Financial Officer

020 7239 8400

Lucy Sharma

VP Investor Relations

020 7239 8427

Martin Robinson / Olivia Peters

Tulchan Communications

020 7353 4200

 

Notes:

1. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions and the effects of changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2020/21 is converted at 2021/22 average exchange rates for the period.  

2. Consensus for the year ended 31 March 2022 (as reported on 30 March 2022) of adjusted profit before tax of £306.0 million within a range of £299.9 million to £313.0 million (source: Electrocomponents.com/investors/analyst-coverage).

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2022 for euro and US dollar were €1.176 and $1.366 respectively. Every 1 cent movement in the euro has a c. £1.8 million impact on annual adjusted profit before tax. Every 1 cent movement in the US dollar has a c. £0.7 million impact on annual adjusted profit before tax.  

4. We expect to see a negative impact of around £7 million on revenue from fewer trading days in 2022/23 compared to 2021/22.  

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFEDSIILLIF
Date   Source Headline
1st Feb 201610:06 amRNSBlocklisting Interim Review
21st Jan 201611:34 amRNSNotice of trading update
4th Jan 20169:13 amRNSTotal Voting Rights
14th Dec 20157:00 amRNSDirectorate Change
1st Dec 201510:15 amRNSHolding(s) in Company
30th Nov 20159:31 amRNSTotal Voting Rights
25th Nov 201511:36 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSFY16 Half-year Financial Report
30th Oct 201510:16 amRNSTotal Voting Rights
9th Oct 20159:35 amRNSHolding(s) in Company
2nd Oct 20157:00 amRNSTrading Update
30th Sep 20152:43 pmRNSDirectorate Change
30th Sep 201511:55 amRNSTotal Voting Rights
24th Sep 201510:46 amRNSNotice of Trading Update
23rd Sep 201511:19 amRNSHolding(s) in Company
8th Sep 201510:47 amRNSChange of Adviser
4th Aug 20154:02 pmRNSAdditional Listing
31st Jul 201511:00 amRNSBlocklisting Interim Review
23rd Jul 20151:57 pmRNSResult of AGM
23rd Jul 20157:00 amRNSFirst Quarter Trading Statement
16th Jul 20159:16 amRNSHolding(s) in Company
6th Jul 20151:43 pmRNSDirector/PDMR Shareholding
1st Jul 20151:33 pmRNSDirector/PDMR Shareholding
30th Jun 201510:34 amRNSTotal Voting Rights
24th Jun 20153:55 pmRNSDirector/PDMR Shareholding
24th Jun 20159:53 amRNSDirector/PDMR Shareholding
19th Jun 201510:31 amRNSNotice of trading update
16th Jun 20152:54 pmRNSAnnual Financial Report
1st Jun 20159:52 amRNSHolding(s) in Company
21st May 20153:10 pmRNSDirector/PDMR Shareholding
21st May 20157:00 amRNSDirectorate Change
21st May 20157:00 amRNSFinal Results
7th May 201510:13 amRNSDirectorate Change
7th May 201510:11 amRNSDirectorate Change
30th Apr 201511:21 amRNSTotal Voting Rights
2nd Apr 20157:00 amRNSTrading Statement
1st Apr 20153:10 pmRNSDirectorate Change
31st Mar 20154:49 pmRNSDirectorate Change
31st Mar 20151:46 pmRNSTotal Voting Rights
13th Mar 20159:26 amRNSNotice of Trading Update
2nd Mar 20152:51 pmRNSDirector/PDMR Shareholding
2nd Mar 201512:24 pmRNSTotal Voting Rights
27th Feb 201510:12 amRNSDirector Declaration
27th Feb 20157:00 amRNSDirectorate Change
11th Feb 20157:00 amRNSTrading Statement
6th Feb 20153:22 pmRNSTotal Voting Rights
6th Feb 20153:01 pmRNSBlocklisting Interim Review
2nd Feb 20152:57 pmRNSBlocklisting Interim Review
2nd Feb 20152:51 pmRNSTotal Voting Rights
15th Jan 20159:47 amRNSNotice of interim management statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.